Catalyst Crew Technologies Corp. (OTC: CCTC) announced the initial launch of its telehealth platform, marking a key milestone in its digital health strategy for emerging markets. The platform is designed to support remote patient engagement, care coordination, and integration of artificial intelligence-driven healthcare analytics tools, according to a company press release.
The platform facilitates communication between patients, healthcare providers, and service participants while enabling structured data collection and workflow coordination across multiple points of care. It is intended to integrate with the company's broader AI healthcare platform, including its CardioAI, PulmoAI, and NeuroAI modules, serving as a foundational infrastructure layer within the company's digital health ecosystem.
Initial deployment is focused on Venezuela, with potential expansion into other Latin American markets as development progresses. The company is leveraging its wholly-owned subsidiary in Venezuela to support local platform operations, coordination, and infrastructure development. The company believes that healthcare systems across Latin America present significant opportunities for digital health solutions, particularly in areas where infrastructure constraints, fragmented care delivery, and limited access to coordinated healthcare services may benefit from scalable, technology-enabled platforms.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: "The initial launch of our telehealth platform represents an important milestone in the execution of our digital health strategy. We are focused on building scalable infrastructure that can support healthcare coordination and data-driven insights, and we believe this platform provides a foundation for continued development and expansion across Latin America."
The initial launch represents an early-stage deployment, with ongoing development, refinement, and expansion expected as the company builds out functionality, integrations, and operational capabilities. The company continues to advance its digital health and AI platform and evaluate opportunities for expansion across emerging markets.
For more information, visit the company's website at https://catalystcrewai.com or review its filings with the U.S. Securities and Exchange Commission at www.sec.gov.
